fda glp-1 compounding crackdown news october 2025 Intensifies on New project announcement: HHS‑OIG is

Preclinical studies in rodents found that GLP-1 receptor agonists stimulate C-cell proliferation in the thyroid the cell type implicated in medullary thyroid carcinoma (MTC)

Yes, shaking can damage the delicate peptide chains, reducing the compounds effectiveness

These symptoms could indicate gastroparesis (severely delayed stomach emptying) or other complications requiring medical assessment

No official medical protocol exists.

Questions Dialysis Patients Should Ask Their Doctor Before starting a GLP-1 medication, ask your healthcare team: Is this medication safe with my dialysis treatment

Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, et al